Temat: "Tumor Burden" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden.
Autorzy:: Femel J; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
van Hooren L; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185, Uppsala, Sweden.; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Oncode Institute, Box 596, 1066CX, Amsterdam, The Netherlands.
Herre M; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
Cedervall J; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
Saupe F; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
Huijbers EJM; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam (CCA), Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Verboogen DRJ; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
Reichel M; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden.
Thijssen VL; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, The Netherlands.
Griffioen AW; Angiogenesis Laboratory, Department of Medical Oncology, Cancer Center Amsterdam (CCA), Amsterdam UMC, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
Hellman L; Department of Cell and Molecular Biology, Uppsala University, Biomedical Center, Box 596, 75124, Uppsala, Sweden.
Dimberg A; Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, 75185, Uppsala, Sweden.
Olsson AK; Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Uppsala University, Biomedical Center, Box 582, 75123, Uppsala, Sweden. .; Pokaż więcej
Źródło:: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Aug; Vol. 71 (8), pp. 2029-2040. Date of Electronic Publication: 2022 Jan 11.
Typ publikacji:: Journal Article
MeSH Terms:: Cancer Vaccines*/immunology
Galectin 1*/metabolism
Melanoma*/therapy
Tumor Burden*
Animals ; Mice ; Neovascularization, Pathologic ; T-Lymphocytes, Cytotoxic/metabolism ; Vaccination

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
Autorzy:: Li WF; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan.
Liu YW; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan.
Wang CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan. .
Yong CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan.
Lin CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, 123 Ta Pei Road, Kaohsiung, Taiwan.
Yen YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, 123 Ta Pei Road, Kaohsiung, Taiwan. .; Pokaż więcej
Źródło:: Langenbeck's archives of surgery [Langenbecks Arch Surg] 2023 May 01; Vol. 408 (1), pp. 169. Date of Electronic Publication: 2023 May 01.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/surgery
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/surgery
Humans ; Tumor Burden ; Neoplasm Staging ; Prognosis

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: High baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway.
Autorzy:: Wen Z; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Sun H; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Zhang Z; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Zheng Y; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Zheng S; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Bin J; Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Liao Y; Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Shi M; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Zhou R; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.
Liao W; Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, P. R. China.; Pokaż więcej
Źródło:: Cancer communications (London, England) [Cancer Commun (Lond)] 2023 May; Vol. 43 (5), pp. 562-581. Date of Electronic Publication: 2023 Apr 08.
Typ publikacji:: Journal Article
MeSH Terms:: B7-H1 Antigen*
Immune Checkpoint Inhibitors*/pharmacology
Immune Checkpoint Inhibitors*/therapeutic use
Animals ; Mice ; Cell Line, Tumor ; CD8-Positive T-Lymphocytes/metabolism ; STAT3 Transcription Factor/metabolism ; Insulin-Like Growth Factor Binding Protein 2/metabolism ; Insulin-Like Growth Factor Binding Protein 2/pharmacology ; Tumor Burden ; Macrophages/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: Prognostic value of metabolic tumor volume of extranodal involvement in diffuse large B cell lymphoma.
Autorzy:: Oiwa K; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Department of Hematology and Oncology, Nagoya City University, Aichi, Japan.
Fujita K; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Department of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-Cho, Hashima-Gun, Gifu, 501-6062, Japan.
Lee S; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan. .; Department of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-Cho, Hashima-Gun, Gifu, 501-6062, Japan. .
Morishita T; Department of Internal Medicine, Matsunami General Hospital, Gifu, Japan.; Department of Healthcare Economics and Quality Management, Graduate School of Medicine, Kyoto University, Yoshida Konoe-Cho, Kyoto, Japan.
Tsujikawa T; Department of Radiology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Negoro E; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Department of Cancer Care Promotion Center, University of Fukui, Fukui, Japan.
Hara T; Department of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-Cho, Hashima-Gun, Gifu, 501-6062, Japan.
Tsurumi H; Department of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-Cho, Hashima-Gun, Gifu, 501-6062, Japan.
Ueda T; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Yamauchi T; Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.; Pokaż więcej
Źródło:: Annals of hematology [Ann Hematol] 2023 May; Vol. 102 (5), pp. 1141-1148. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:: Journal Article
MeSH Terms:: Fluorodeoxyglucose F18*
Lymphoma, Large B-Cell, Diffuse*
Humans ; Prognosis ; Tumor Burden ; Retrospective Studies ; Positron-Emission Tomography

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden.
Autorzy:: Mu J; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Deng H; The First Central Clinical College of Tianjin Medical University, Tianjin, China.
Lyu C; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Yuan J; Shanghai Genbase Biotechnology Co., Ltd., Shanghai, China.
Li Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Wang J; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Jiang Y; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Deng Q; Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Shen J; Department of Hematology, Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin, China.; Pokaż więcej
Źródło:: Hematological oncology [Hematol Oncol] 2023 Apr; Vol. 41 (2), pp. 275-284. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Receptors, Chimeric Antigen*/therapeutic use
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Tumor Burden ; Antigens, CD19 ; T-Lymphocytes ; Apoptosis

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Automated quantification of PET/CT skeletal tumor burden in prostate cancer using artificial intelligence: The PET index.
Autorzy:: Lindgren Belal S; Division of Nuclear Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden. sarah.lindgren_.; Department of Surgery, Skåne University Hospital, Malmö, Sweden. sarah.lindgren_.; Wallenberg Center for Molecular Medicine, Lund University, Malmö, Sweden. sarah.lindgren_.
Larsson M; Eigenvision AB, Malmö, Sweden.
Holm J; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Buch-Olsen KM; Department of Nuclear Medicine, Odense University Hospital, Odense, Denmark.
Sörensen J; Division of Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Bjartell A; Division of Urological Cancer, Department of Translational Medicine, Lund University, Malmö, Sweden.
Edenbrandt L; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Trägårdh E; Division of Nuclear Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Malmö, Sweden.; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Apr; Vol. 50 (5), pp. 1510-1520. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Prostatic Neoplasms*/diagnostic imaging
Male ; Humans ; Artificial Intelligence ; Tumor Burden ; Positron-Emission Tomography

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: Albumin-Bilirubin Grade and Tumor Burden Score Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma After Hepatic Resection: a Multi-Institutional Analysis.
Autorzy:: Munir MM; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Endo Y; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Lima HA; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Alaimo L; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Moazzam Z; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Shaikh C; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
Poultsides GA; Department of Surgery, Stanford University, Stanford, CA, USA.
Guglielmi A; Department of Surgery, University of Verona, Verona, Italy.
Aldrighetti L; Department of Surgery, Ospedale San Raffaele, Milan, Italy.
Weiss M; Department of Surgery, John Hopkins Hospital, Baltimore, MA, USA.
Bauer TW; Department of Surgery, University of Virginia, Charlottesville, VA, USA.
Alexandrescu S; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
Kitago M; Department of Surgery, Keio University, Tokyo, Japan.
Maithel SK; Department of Surgery, Emory University, Atlanta, GA, USA.
Marques HP; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
Martel G; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
Pulitano C; Department of Surgery, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.
Shen F; Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Shanghai, China.
Cauchy F; Department of Hepatibiliopancreatic Surgery, APHP, Beaujon Hospital, Clichy, France.
Koerkamp BG; Department of Surgery, Erasmus University Medical Centre, Rotterdam, Netherlands.
Endo I; Department of Gastroenterological Surgery, Yokohama City, University School of Medicine, Yokohama, Japan.
Pawlik TM; Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA. .; Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, Columbus, OH, USA. .; Health Services Management and Policy, The Ohio State University, Wexner Medical Center, 395 W. 12Th Ave., Suite 670, Columbus, OH, USA. .; Pokaż więcej
Źródło:: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract [J Gastrointest Surg] 2023 Mar; Vol. 27 (3), pp. 544-554. Date of Electronic Publication: 2023 Jan 18.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Cholangiocarcinoma*/surgery
Liver Neoplasms*/surgery
Bile Duct Neoplasms*/surgery
Carcinoma, Hepatocellular*/surgery
Humans ; Bilirubin ; Tumor Burden ; Serum Albumin ; Prognosis ; Bile Ducts, Intrahepatic ; Retrospective Studies

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: Effective dose window for containing tumor burden under tolerable level.
Autorzy:: Masud MA; Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, 25451, Republic of Korea.
Kim JY; Graduate School of Analytical Science and Technology (GRAST), Chungnam National University, Daejeon, 34134, Republic of Korea.
Kim E; Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, 25451, Republic of Korea. .; Pokaż więcej
Źródło:: NPJ systems biology and applications [NPJ Syst Biol Appl] 2023 May 23; Vol. 9 (1), pp. 17. Date of Electronic Publication: 2023 May 23.
Typ publikacji:: Journal Article
MeSH Terms:: Melanoma*
Humans ; Tumor Burden

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Tytuł:: Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis.
Autorzy:: Lee H; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Hyun SH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Cho YS; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Moon SH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Choi JY; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Kim K; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Lee KH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 15; Vol. 13 (1), pp. 7881. Date of Electronic Publication: 2023 May 15.
Typ publikacji:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*/methods
Multiple Myeloma*/diagnostic imaging
Multiple Myeloma*/metabolism
Humans ; Fluorodeoxyglucose F18 ; Artificial Intelligence ; Retrospective Studies ; Prognosis ; Cluster Analysis ; Tumor Burden ; Radiopharmaceuticals ; Positron-Emission Tomography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Not all TMB assays are the same: Clinical validity of robust algorithmic germline filtering.
Autorzy:: Huang RSP; Foundation Medicine, Inc, Cambridge, MA, USA. Electronic address: .
Graf RP; Foundation Medicine, Inc, Cambridge, MA, USA.
Oxnard GR; Foundation Medicine, Inc, Cambridge, MA, USA.; Pokaż więcej
Źródło:: Cancer cell [Cancer Cell] 2023 May 08; Vol. 41 (5), pp. 819-820. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:: Letter
MeSH Terms:: Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/pathology
Humans ; Mutation ; Tumor Burden ; Germ-Line Mutation ; Biomarkers, Tumor

Opinia redakcyjna

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Automatic detection and recognition of nasopharynx gross tumour volume (GTVnx) by deep learning for nasopharyngeal cancer radiotherapy through magnetic resonance imaging.
Autorzy:: Wang Y; Faculty of Computer Science and Technology, Wenzhou University, WenZhou, China.
Chen H; College of Intelligent Manufacturing, Wenzhou Polytechnic, Wenzhou, China.
Lin J; Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, WenZhou, China.
Dong S; Department of Radiotherapy, Wenzhou Central Hospital, Dingli Clinical Medical School of Wenzhou Medical University, Wenzhou, China.
Zhang W; Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University, WenZhou, China. .; Pokaż więcej
Źródło:: Radiation oncology (London, England) [Radiat Oncol] 2023 May 08; Vol. 18 (1), pp. 76. Date of Electronic Publication: 2023 May 08.
Typ publikacji:: Journal Article
MeSH Terms:: Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/radiotherapy
Deep Learning*
Humans ; Tumor Burden ; Nasopharyngeal Carcinoma/diagnostic imaging ; Nasopharyngeal Carcinoma/radiotherapy ; Magnetic Resonance Imaging ; Nasopharynx/diagnostic imaging

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after I Particle Therapy for Differentiated Thyroid Cancer.
Autorzy:: Tan L; Department of Nuclear Medicine, The Second Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, China.
Chen Z; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.
Wang W; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.
Su Y; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.
Wu Z; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.
Yi L; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.
Zheng Z; Department of Nuclear Medicine, Jiangxi Tumor Hospital, Nanchang, Jiangxi, China.; Pokaż więcej
Źródło:: Mediators of inflammation [Mediators Inflamm] 2023 May 03; Vol. 2023, pp. 8130422. Date of Electronic Publication: 2023 May 03 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Thyroid Neoplasms*/radiotherapy
Adenocarcinoma, Follicular*
Humans ; Tumor Burden ; Lymphocytes ; Prognosis ; Neutrophils ; Blood Platelets ; Monocytes ; Retrospective Studies ; Thyrotropin

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy.
Autorzy:: Pollock AE; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Arons D; University of Maryland School of Medicine, Baltimore, Maryland, USA.
Alexander GS; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Alicia D; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Birkman KM; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Molitoris JK; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Mehra R; Department of Medicine, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Cullen KJ; Department of Medicine, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Hatten KM; Department of Otolaryngology, Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Taylor RJ; Department of Otolaryngology, Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wolf JS; Department of Otolaryngology, Head and Neck Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Regine WF; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
Witek ME; Department of Radiation Oncology, University of Maryland, School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Head & neck [Head Neck] 2023 May; Vol. 45 (5), pp. 1088-1096. Date of Electronic Publication: 2023 Feb 25.
Typ publikacji:: Journal Article
MeSH Terms:: Proton Therapy*/methods
Oropharyngeal Neoplasms*/etiology
Radiotherapy, Intensity-Modulated*/methods
Humans ; Retrospective Studies ; Tumor Burden ; Positron Emission Tomography Computed Tomography ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: The effect of primary tumor volume on the prognosis of nasopharyngeal carcinoma in era of volumetric modulated arc therapy: a propensity score matched cohort study.
Autorzy:: Lin X; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Radiation Oncology, Fujian, China.
Wang B; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Radiation Oncology, Fujian, China.
Zheng F; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Radiation Oncology, Fujian, China.
Fei Z; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Radiation Oncology, Fujian, China.
Chen C; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Department of Radiation Oncology, Fujian, China. Electronic address: .; Pokaż więcej
Źródło:: Brazilian journal of otorhinolaryngology [Braz J Otorhinolaryngol] 2023 May-Jun; Vol. 89 (3), pp. 374-382. Date of Electronic Publication: 2023 Feb 16.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma*/radiotherapy
Radiotherapy, Intensity-Modulated*/adverse effects
Nasopharyngeal Neoplasms*/radiotherapy
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Nasopharyngeal Carcinoma/pathology ; Cohort Studies ; Retrospective Studies ; Propensity Score ; Tumor Burden ; Prognosis ; Neoplasm Staging

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 15.

Tytuł:: Detection of intraductal carcinoma in prostate cancer patients with small tumor volume.
Autorzy:: Takeshita N; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Sakamoto S; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Yamada Y; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Sazuka T; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Imamura Y; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Komiya A; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.
Akakura K; Department of Urology, Japan Community Health Care Organization, Tokyo, Japan.
Sato N; Department of Urology, Funabashi Municipal Medical Center, Chiba, Japan.
Nakatsu H; Department of Urology, Asahi General Hospital, Chiba, Japan.
Kato T; Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan.
Sugimoto M; Department of Urology, Kagawa University Faculty of Medicine, Kagawa, Japan.
Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Aichi, Japan.
Ichikawa T; Department of Urology, Chiba University Graduate School of Medicine, Chiba, Japan.; Pokaż więcej
Źródło:: The Prostate [Prostate] 2023 May; Vol. 83 (6), pp. 580-589. Date of Electronic Publication: 2023 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Intraductal, Noninfiltrating*/pathology
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Tumor Burden ; Retrospective Studies ; Prostate/pathology ; Prostatectomy/methods ; Prostate-Specific Antigen

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: The reproducibility of MTV and TLG of soft tissue tumors calculated by FDG-PET: Comparison between the lower limit by the fixed value SUV 2.5 and that value by 30% of SUVmax.
Autorzy:: Iwasa H; Department of Radiology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.; Department of Diagnostic and Interventional Radiology, Kochi Medical School, Kochi University, Kochi, Japan.
Nagamachi S; Department of Radiology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan. .
Nakayama S; Department of Orthopedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yamamoto T; Department of Orthopedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Yoshimitsu K; Department of Radiology, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, 814-0180, Japan.; Pokaż więcej
Źródło:: Japanese journal of radiology [Jpn J Radiol] 2023 May; Vol. 41 (5), pp. 531-540. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:: Journal Article
MeSH Terms:: Fluorodeoxyglucose F18*
Positron Emission Tomography Computed Tomography*
Humans ; Tumor Burden ; Retrospective Studies ; Reproducibility of Results ; Glycolysis ; Prognosis ; Radiopharmaceuticals

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Tumor Volume Is a Better Prognostic Factor than Greatest Tumor Diameter in Operated Stage I-III Non-Small-Cell Lung Cancer.
Autorzy:: Duran AO; Department of Medical Oncology, Health Science University, Ankara Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Ankara, Turkey. Electronic address: .
Inanc M; Department of Medical Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.
Bozkurt O; Department of Medical Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.
Ozaslan E; Department of Medical Oncoloy, Kayseri Acibadem Hospital, Kayseri, Turkey.
Ozkan M; Department of Medical Oncology, Erciyes University, School of Medicine, Kayseri, Turkey.; Pokaż więcej
Źródło:: Clinical lung cancer [Clin Lung Cancer] 2023 May; Vol. 24 (3), pp. 252-259. Date of Electronic Publication: 2023 Mar 04.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Prognosis ; Tumor Burden ; Retrospective Studies ; Neoplasm Staging

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 18.

Tytuł:: Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma.
Autorzy:: Chen Q; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China.
Shen L; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China.; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China.
Li S; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China. .; National Clinical Research Center for Geriatric Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China. .; Pokaż więcej
Źródło:: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2023 May; Vol. 280 (5), pp. 2497-2509. Date of Electronic Publication: 2022 Dec 27.
Typ publikacji:: Journal Article
MeSH Terms:: Cisplatin*/therapeutic use
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/pathology ; Gemcitabine ; Induction Chemotherapy ; Retrospective Studies ; Tumor Burden ; Deoxycytidine

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Anatomical site and size of sentinel lymph node metastasis predicted additional axillary tumour burden and breast cancer survival.
Autorzy:: Lai BS; Department of Pathology, North District Hospital, Hong Kong.
Tsang JY; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, NT, Shatin, Hong Kong.
Li JJ; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, NT, Shatin, Hong Kong.
Poon IK; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, NT, Shatin, Hong Kong.
Tse GM; Department of Anatomical and Cellular Pathology and State Key Laboratory of Translational Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, NT, Shatin, Hong Kong.; Pokaż więcej
Źródło:: Histopathology [Histopathology] 2023 May; Vol. 82 (6), pp. 899-911. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Sentinel Lymph Node*/pathology
Humans ; Female ; Lymphatic Metastasis/pathology ; Tumor Burden ; Breast/pathology ; Sentinel Lymph Node Biopsy/methods ; Lymph Nodes/pathology ; Lymph Node Excision ; Axilla/pathology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Prioritizing sufficient dose to gross tumor volume over normal tissue sparing in intensity-modulated radiotherapy treatment of T4 nasopharyngeal carcinoma.
Autorzy:: Chen Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fuzhou, China.; Department of Radiation Oncology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Fuzhou, China.; Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies), Fuzhou, China.
Zhang Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Lu T; Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang, China.
Hu C; Department of Radiology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Zong J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Xu Y; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Zheng W; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Chen L; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Lin S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Qiu S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Xu L; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Pan J; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.
Guo Q; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, Fujian, China.; Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Lin S; Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.; Pokaż więcej
Źródło:: Head & neck [Head Neck] 2023 May; Vol. 45 (5), pp. 1130-1140. Date of Electronic Publication: 2023 Mar 01.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Radiotherapy, Intensity-Modulated*/adverse effects
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/radiotherapy ; Tumor Burden ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Tumor Burden"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język